Pune based startup Mylab Discovery Solutions that had launched the first indigenous RT-PCR testing kit is now stepping into antigen testing kits with the commercial approval from the ICMR. This development now adds another product to Mylab’s suite of testing solutions for COVID-19 virus.

It is the first truly Indian company kit to receive commercial approval from ICMR and is named as Pathocatch COVID-19 Antigen Rapid testing kit.

The launch of antigen testing kit is in line with the government's expectation to increase rapid testing which is the Point-of-Care method and complements the more rigorous RT-PCR (Reverse transcription polymerase chain reaction) test to detect coronavirus. As infections surge across the country, more states are now allowing antigen-based rapid testing in India.

Hasmukh Rawal, MD, Mylab Discovery Solutions said, “Mylab team is working really hard to fight this pandemic in every possible way. After bringing an affordable RT-PCR test to reduce dependence on foreign kits, we launched Compact XL to accelerate COVID-19 testing. Now, with the approval for an antigen testing kit, we will cover whole spectrum of COVID-19 testing and leave no stone unturned to fight this pandemic.”

The kit is developed and manufactured in India. The kit will be available for orders immediately and will be priced around INR 450.